Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Marsh (NYSE: MRSH) SEC filings page on Stock Titan is designed to help investors and analysts review the company’s regulatory disclosures in a structured way. While recent SEC filings are not listed in the available data, this page is where users can access Marsh’s future submissions to the US Securities and Exchange Commission once they are posted to EDGAR.
For a company that describes itself as a global leader in risk, reinsurance and capital, people and investments, and management consulting, key filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q can provide important detail on business segments, risk factors, and financial performance. Current reports on Form 8-K may highlight material events, including dividend declarations or other board decisions affecting Marsh’s common stock.
When available, proxy statements and related filings can offer additional information on governance and executive matters, while Form 4 filings can be used to track transactions by directors and certain officers in Marsh’s equity.
Stock Titan enhances these documents with AI-powered summaries that explain the main points of lengthy filings in accessible language. Users can quickly see what has changed from one period to the next, identify notable disclosures, and then drill into the full text for deeper analysis. Real-time updates from EDGAR ensure that new Marsh filings appear promptly, while AI-generated insights help reduce the time required to interpret complex regulatory documents.
HANWAY H EDWARD reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director H. Edward Hanway received an annual stock award of 1,349 shares of Common Stock. The award was granted on June 1, 2026 under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
After this grant, Hanway directly holds a total of 36,867.7 shares of Marsh & McLennan common stock. This is a compensation-related equity award, not an open‑market purchase or sale.
HANWAY H EDWARD reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director H. Edward Hanway received an annual stock award of 1,349 shares of Common Stock. The award was granted on June 1, 2026 under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
After this grant, Hanway directly holds a total of 36,867.7 shares of Marsh & McLennan common stock. This is a compensation-related equity award, not an open‑market purchase or sale.
Hartmann Judith reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Judith Hartmann received an annual stock award of 1,349 shares of Common Stock. The shares were granted on June 1, 2026 at a reported price of $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan.
Following this grant, Hartmann directly holds 4,323 shares of the company’s common stock. This is a compensation-related award rather than an open-market purchase, so it reflects standard director remuneration rather than a trading decision based on the share price.
Hartmann Judith reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Judith Hartmann received an annual stock award of 1,349 shares of Common Stock. The shares were granted on June 1, 2026 at a reported price of $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan.
Following this grant, Hartmann directly holds 4,323 shares of the company’s common stock. This is a compensation-related award rather than an open-market purchase, so it reflects standard director remuneration rather than a trading decision based on the share price.
Marsh & McLennan Companies director Peter Harrison reported compensation-related stock transactions. He received an annual stock award of 1,349 shares of common stock under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
To cover applicable taxes on shares acquired with director fees under the same plan, 103.39 shares of common stock were withheld in a tax-withholding disposition. After these transactions and receipt of cash in lieu of a fractional share, Harrison directly holds 1,349.82 shares of Marsh & McLennan common stock.
Marsh & McLennan Companies director Peter Harrison reported compensation-related stock transactions. He received an annual stock award of 1,349 shares of common stock under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
To cover applicable taxes on shares acquired with director fees under the same plan, 103.39 shares of common stock were withheld in a tax-withholding disposition. After these transactions and receipt of cash in lieu of a fractional share, Harrison directly holds 1,349.82 shares of Marsh & McLennan common stock.
BROUSSARD BRUCE D reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Bruce D. Broussard received an annual stock award of 1,349 shares of common stock on June 1, 2026 under the company’s Directors Stock Compensation Plan. The grant was valued at $159.28 per share and increased his direct holdings to 1,425 shares.
BROUSSARD BRUCE D reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Bruce D. Broussard received an annual stock award of 1,349 shares of common stock on June 1, 2026 under the company’s Directors Stock Compensation Plan. The grant was valued at $159.28 per share and increased his direct holdings to 1,425 shares.
John Q. Doyle submitted a Form 144 notifying a proposed sale of 16,656 shares of Common Stock to be sold on 06/02/2026. The filing lists an option granted 02/22/2017 as the acquisition event and names Fidelity Brokerage Services LLC as the broker. A prior sale entry on 03/04/2026 shows $3,052,861.50 associated with 16,655 (listed nearby in the excerpt).
John Q. Doyle submitted a Form 144 notifying a proposed sale of 16,656 shares of Common Stock to be sold on 06/02/2026. The filing lists an option granted 02/22/2017 as the acquisition event and names Fidelity Brokerage Services LLC as the broker. A prior sale entry on 03/04/2026 shows $3,052,861.50 associated with 16,655 (listed nearby in the excerpt).
Marsh & McLennan Companies, Inc. held its Annual Meeting of Stockholders on May 21, 2026, with 436,451,305 shares represented, or 90.34% of the 483,095,948 shares of common stock entitled to vote. Stockholders elected thirteen directors to one-year terms expiring at the 2027 annual meeting or until their successors are elected and qualified.
Stockholders also approved, on a nonbinding basis, the compensation of the company’s named executive officers, with 362,069,913 shares voted for, 47,108,150 against and 2,053,496 abstentions, and ratified the selection of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
Marsh & McLennan Companies, Inc. held its Annual Meeting of Stockholders on May 21, 2026, with 436,451,305 shares represented, or 90.34% of the 483,095,948 shares of common stock entitled to vote. Stockholders elected thirteen directors to one-year terms expiring at the 2027 annual meeting or until their successors are elected and qualified.
Stockholders also approved, on a nonbinding basis, the compensation of the company’s named executive officers, with 362,069,913 shares voted for, 47,108,150 against and 2,053,496 abstentions, and ratified the selection of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
Marsh & McLennan Companies director Morton O. Schapiro reported routine equity compensation activity. On May 15, 2026, he received 256.85 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, valued at $160.60 per unit. A separate adjustment of 495.08 restricted stock units reflects dividend equivalents credited under the same plan. Each restricted stock unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis, and Schapiro now holds more than 88,000 restricted stock units directly.
Marsh & McLennan Companies director Morton O. Schapiro reported routine equity compensation activity. On May 15, 2026, he received 256.85 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, valued at $160.60 per unit. A separate adjustment of 495.08 restricted stock units reflects dividend equivalents credited under the same plan. Each restricted stock unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis, and Schapiro now holds more than 88,000 restricted stock units directly.
MARSH & MCLENNAN COMPANIES, INC. director Deborah C. Hopkins reported an administrative Form 4 update related to her director stock compensation. On 2026-05-15, 111.82 restricted stock units were credited to her account at a reference price of $160.60 per unit through dividend equivalents.
These restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Hopkins directly holds a total of 20,064.74 restricted stock units under the directors stock compensation plan.
MARSH & MCLENNAN COMPANIES, INC. director Deborah C. Hopkins reported an administrative Form 4 update related to her director stock compensation. On 2026-05-15, 111.82 restricted stock units were credited to her account at a reference price of $160.60 per unit through dividend equivalents.
These restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Hopkins directly holds a total of 20,064.74 restricted stock units under the directors stock compensation plan.
MARSH & MCLENNAN COMPANIES, INC. director Tamara Ingram reported a routine compensation-related adjustment to her equity holdings. She received 43.11 restricted stock units under the Directors Stock Compensation Plan, credited as dividend equivalents and tied to the company’s common stock on a 1-for-1 basis.
Following this transaction, Ingram holds a total of 7,736.53 restricted stock units directly. The filing does not reflect any open-market purchase or sale of Marsh & McLennan common shares, but rather an administrative update to her stock-based compensation balance.
MARSH & MCLENNAN COMPANIES, INC. director Tamara Ingram reported a routine compensation-related adjustment to her equity holdings. She received 43.11 restricted stock units under the Directors Stock Compensation Plan, credited as dividend equivalents and tied to the company’s common stock on a 1-for-1 basis.
Following this transaction, Ingram holds a total of 7,736.53 restricted stock units directly. The filing does not reflect any open-market purchase or sale of Marsh & McLennan common shares, but rather an administrative update to her stock-based compensation balance.
Marsh & McLennan Companies director Lloyd M. Yates reported routine stock-based compensation activity involving restricted stock units that convert into common stock on a 1-for-1 basis. He received a grant of 225.720 restricted stock units in connection with director fees under the Directors Stock Compensation Plan.
In a separate restructuring-type entry, 60.270 restricted stock units were acquired through dividend equivalents credited to his account. Following these transactions, Yates directly holds about 11,041.170 restricted stock units, reflecting ongoing equity-based compensation rather than open-market trading.
Marsh & McLennan Companies director Lloyd M. Yates reported routine stock-based compensation activity involving restricted stock units that convert into common stock on a 1-for-1 basis. He received a grant of 225.720 restricted stock units in connection with director fees under the Directors Stock Compensation Plan.
In a separate restructuring-type entry, 60.270 restricted stock units were acquired through dividend equivalents credited to his account. Following these transactions, Yates directly holds about 11,041.170 restricted stock units, reflecting ongoing equity-based compensation rather than open-market trading.